CAPTRUST Financial Advisors’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,167
| Closed | -$14K | – | 2238 |
|
|
2022
Q3 | $14K | Buy |
3,167
+3,000
| +1,796% | +$13.3K | ﹤0.01% | 2024 |
|
|
2022
Q2 | $1K | Buy |
+167
| New | +$1K | ﹤0.01% | 4816 |
|
|
2022
Q1 | – | Sell |
-647
| Closed | -$13K | – | 5235 |
|
|
2021
Q4 | $13K | Sell |
647
-845
| -57% | -$17K | ﹤0.01% | 3582 |
|
|
2021
Q3 | $39K | Sell |
1,492
-4,438
| -75% | -$116K | ﹤0.01% | 2753 |
|
|
2021
Q2 | $130K | Sell |
5,930
-68
| -1% | -$1.49K | ﹤0.01% | 1825 |
|
|
2021
Q1 | $140K | Buy |
5,998
+306
| +5% | +$7.14K | ﹤0.01% | 1733 |
|
|
2020
Q4 | $98K | Buy |
5,692
+992
| +21% | +$17.1K | ﹤0.01% | 1510 |
|
|
2020
Q3 | $78K | Buy |
4,700
+700
| +18% | +$11.6K | ﹤0.01% | 1453 |
|
|
2020
Q2 | $58K | Buy |
+4,000
| New | +$58K | ﹤0.01% | 1571 |
|